These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 6398336)

  • 41. Dopaminergic inhibition of metoclopramide-induced aldosterone secretion in man. Dissociation of responses to dopamine and bromocriptine.
    Carey RM; Thorner MO; Ortt EM
    J Clin Invest; 1980 Jul; 66(1):10-8. PubMed ID: 7400305
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Age- and sex-related differences in plasma aldosterone in essential hypertension. Relationship to plasma renin activity.
    Vetter H; Glänzer K; Alasso I; Vetter W
    Klin Wochenschr; 1979 May; 57(9):445-9. PubMed ID: 449254
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Dopaminergic regulation of 18-hydroxycorticosterone and aldosterone secretion in man.
    Sowers JR; Beck FW
    Acta Endocrinol (Copenh); 1983 Feb; 102(2):258-64. PubMed ID: 6338674
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Effects of circadian rhythms, posture, and medication on renin-aldosterone interrelations in essential hypertensives.
    Lamarre-Cliche M; de Champlain J; Lacourcière Y; Poirier L; Karas M; Larochelle P
    Am J Hypertens; 2005 Jan; 18(1):56-64. PubMed ID: 15691618
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Effects of metoclopramide and bromocriptine on the renin-angiotensin-aldosterone system in man. Dopaminergic control of aldosterone.
    Carey RM; Thorner MO; Ortt EM
    J Clin Invest; 1979 Apr; 63(4):727-35. PubMed ID: 438333
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Decreased central dopaminergic activity in essential hypertension.
    Os I; Kjeldsen SE; Westheim A; Aakesson I; Norman N; Enger E; Hjermann I; Eide I
    J Hypertens; 1987 Apr; 5(2):191-7. PubMed ID: 3611768
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Effect of metoclopramide on the secretion of aldosterone and other adrenocortical steroids.
    Nagahama S; Fujimaki M; Kawabe H; Nakamura R; Saito I; Saruta T
    Clin Endocrinol (Oxf); 1983 Mar; 18(3):287-93. PubMed ID: 6861367
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Rapid increase of mineralocorticoids after furosemide in low-renin essential hypertension: evidence for 18-hydroxycorticosterone to be a better marker than aldosterone.
    Witzgall H; Thayil G; Weber PC
    Klin Wochenschr; 1982 Aug; 60(16):847-52. PubMed ID: 6752560
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Alterations in aldosterone secretion and metabolism in low renin hypertension.
    Griffing GT; Wilson TE; Melby JC
    J Clin Endocrinol Metab; 1990 Dec; 71(6):1454-60. PubMed ID: 2229301
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Dopaminergic Modulation of renin activity and aldosterone and prolactin secretion in the spontaneously hypertensive rat.
    Sowers JR; Sollars EG; Tuck ML; Asp ND
    Proc Soc Exp Biol Med; 1980 Sep; 164(4):598-603. PubMed ID: 6997889
    [No Abstract]   [Full Text] [Related]  

  • 51. Effect of propranolol therapy on aldosterone responses to angiotensin II and adrenocorticotropic hormone in essential hypertension.
    Golub MS; Tuck ML; Fittingoff DB
    Clin Sci (Lond); 1981 Jul; 61(1):107-10. PubMed ID: 6265141
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Dopaminergic regulation of aldosterone secretion: assessment in different subtypes of primary aldosteronism and in essential hypertension.
    Veglio F; Pinna G; Rabbia F; Panarelli M; Bisbocci D; Melchio R; Chiandussi L
    J Int Med Res; 1991; 19(1):44-9. PubMed ID: 1850365
    [TBL] [Abstract][Full Text] [Related]  

  • 53. The effect of metoclopramide and haloperidol on plasma renin activity and aldosterone levels in rats.
    Jungmann E; Wächtler M; Schwedes U; Usadel KH; Schöffling K
    Res Exp Med (Berl); 1983; 183(2):133-8. PubMed ID: 6361937
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Studies of the control of plasma aldosterone concentration in normal man. I. Response to posture, acute and chronic volume depletion, and sodium loading.
    Williams GH; Cain JP; Dluhy RG; Underwood RH
    J Clin Invest; 1972 Jul; 51(7):1731-42. PubMed ID: 4338121
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Angiotensin II in primary hypertension, relationship to plasma renin activity, aldosterone and urinary electrolytes.
    Tolagen K; Karlberg BE
    Acta Med Scand; 1979; 205(7):557-62. PubMed ID: 474181
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Dopamine and nonmodulating hypertension.
    Williams GH; Gordon MS; Stuenkel CA; Conlin PR; Hollenberg NK
    Am J Hypertens; 1990 Jun; 3(6 Pt 2):112S-115S. PubMed ID: 2383375
    [TBL] [Abstract][Full Text] [Related]  

  • 57. In vivo and in vitro effects of metoclopramide on aldosterone secretion in rats.
    Nagahama S; Fujimaki M; Suzuki H; Kawabe H; Saito I; Saruta T
    Acta Endocrinol (Copenh); 1983 Apr; 102(4):589-93. PubMed ID: 6342328
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Unaltered dopaminergic modulation of aldosterone secretion in cirrhosis.
    Bernardi M; De Palma R; Trevisani F; Malatesta R; Baraldini M; Cursaro C; Gasbarrini G
    Clin Sci (Lond); 1988 Feb; 74(2):137-43. PubMed ID: 3338258
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Dopamine inhibits the aldosterone response to upright posture.
    Malchoff CD; Hughes J; Sen S; Jackson S; Carey RM
    J Clin Endocrinol Metab; 1986 Jul; 63(1):197-201. PubMed ID: 3519647
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Plasma levels of brain natriuretic peptide in healthy subjects and patients with essential hypertension: response to posture.
    La Villa G; Vena S; Conti A; Fronzaroli C; Brat A; Lazzeri C; Tosti Guerra C; Madiai S; Marra N; Franchi F
    Clin Sci (Lond); 1993 Oct; 85(4):411-6. PubMed ID: 8222505
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.